JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 3,651 articles

Articles by James Calloway

Marvell Stock Surges 5% as Analysts Lift Targets Ahead of Q2 Report
Earnings

Marvell Stock Surges 5% as Analysts Lift Targets Ahead of Q2 Report

Marvell shares climbed 5% after analysts raised price targets, with options pricing a 10.6% earnings swing ahead of Thursday's report.

MRVL
Starbucks' Autumn Menu Launch Tests North American Profitability
Earnings

Starbucks' Autumn Menu Launch Tests North American Profitability

Starbucks launched its fall menu with six pumpkin drinks, aiming to boost traffic and margins. North America revenue hit $7.40B with a 13.6% margin.

SBUX
Scotiabank Hits Record Profit, ROE Exceeds Target, Shares Jump 5%
Earnings

Scotiabank Hits Record Profit, ROE Exceeds Target, Shares Jump 5%

Scotiabank shares jumped 5% after record quarterly profit lifted adjusted ROE to 14.2%, above its 14% target and beating analyst forecasts. Revenue rose 11.1%.

BNS CM TD RY BMO
Vitruvias Thyroid Tablet Recall Triggers Potency Checks for 1.5M Patients
Regulation

Vitruvias Thyroid Tablet Recall Triggers Potency Checks for 1.5M Patients

Vitruvias Therapeutics recalls one lot of Thyroid Tablets 30 mg due to superpotency. 1,955 units sold; FDA scrutiny on unapproved animal-derived thyroid meds rises.

Cuban Proposes Tax Penalty for Firms Denying Employee Equity
Regulation

Cuban Proposes Tax Penalty for Firms Denying Employee Equity

Mark Cuban proposes taxing companies that don't offer equity to all employees. A 2% tax increase would match a 1% payroll stock grant, per analysis.

AMZN
Dick's Sporting Goods Stock Plunges 16% on Weak Foot Locker Outlook
Earnings

Dick's Sporting Goods Stock Plunges 16% on Weak Foot Locker Outlook

DKS shares tumbled 16% premarket after Q2 earnings and revenue missed estimates, prompting a cut to full-year guidance due to weakness at Foot Locker.

DKS
Nvidia (NVDA) Earnings Preview: Options Signal Muted Move as Revenue Test Looms
Earnings

Nvidia (NVDA) Earnings Preview: Options Signal Muted Move as Revenue Test Looms

Nvidia (NVDA) rises 1.3% premarket before Q2 earnings; options imply a 5.4% move, a subdued signal. Revenue forecast at $92.18B, with margin and Rubin timeline key.

NVDA
DHS H-1B Fee Hike to $103,265 Could Reshape Tech Hiring Costs
Regulation

DHS H-1B Fee Hike to $103,265 Could Reshape Tech Hiring Costs

The DHS proposes a $103,265 fee for new H-1B visas, up to 52x the old cost, potentially reshaping tech hiring strategies and impacting major employers.

AMZN AAPL MSFT
A$372B Super at Risk in Australia's CGT Overhaul
Regulation

A$372B Super at Risk in Australia's CGT Overhaul

Industry modelling shows proposed trust rules could increase effective tax rates on A$372 billion in Australian super assets, a 50% relative jump for affected gains.

EWA
49ers Governance Risk Looms Over $8.5B Valuation After York Plea
Regulation

49ers Governance Risk Looms Over $8.5B Valuation After York Plea

Jed York's no-contest plea to misdemeanors triggers NFL review, casting governance uncertainty over the $8.5B 49ers valuation and its global sports portfolio.

MANU
Target Stock Hits Record High Despite Halloween Costume Recall
Earnings

Target Stock Hits Record High Despite Halloween Costume Recall

Target shares rose 2.7% to an all-time high of $169.89 after the retailer removed an offensive Halloween costume, while its Q2 earnings and holiday lineup boost investor confidence.

TGT
Bloom Energy Rebounds, Yet Valuation Concerns Loom After 42% Slide
Earnings

Bloom Energy Rebounds, Yet Valuation Concerns Loom After 42% Slide

Bloom Energy (BE) shares rebounded 1% Monday, but remain 42% off highs. Despite Q2 revenue surging 165.5%, the stock's valuation at 14.8x forward sales tests investor patience.

BE BAM AEP EQIX ORCL